Related Experiment Videos
Topiramate for phantom limb pain: a time-series analysis
R Norman Harden1, Tim T Houle, Thomas A Remble
1Center for Pain Studies, Rehabilitation Institute of Chicago/Northwestern University Medical School, Chicago, Illinois 60611, USA. nharden@rehabchicago.org
Pain Medicine (Malden, Mass.)
|November 4, 2005
Summary
Topiramate shows promise for treating neuropathic pain, particularly phantom limb pain in amputees. A study found significant pain reduction in three of four participants, suggesting further research is warranted.
Area of Science:
- Neurology
- Pain Management
- Pharmacology
Background:
- Neuropathic pain, especially phantom limb pain (PLP) in amputees, presents a significant clinical challenge.
- Topiramate, an anticonvulsant, is increasingly recognized for its potential in managing various pain conditions.
Observation:
- This study analyzed the effects of topiramate on four amputee subjects experiencing phantom limb pain.
- Individual time-series analyses were employed to assess pain response over time.
Findings:
- Three out of four participants demonstrated statistically significant reductions in phantom limb pain.
- The most pronounced pain relief was observed at a daily dosage of 800 mg of topiramate.
Implications:
- These findings support the hypothesis that topiramate may be an effective treatment for reducing phantom limb pain.
- A larger, definitive clinical study is recommended to confirm these preliminary results and establish optimal dosing strategies.